Key facts
- It has raised $630K across 1 recorded rounds; the latest was Seed Round ($625K) in Dec 2024.
- Posteros has filed 1 Form D with the SEC, most recently Dec 2024 ($625K sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Posteros
Funding rounds
1 roundsAbout Posteros
Developer of a medical intelligence engine designed to provide insight-driven technology to medical science liaison teams. The company builds tools that capture and amplify strategic scientific intelligence, allowing multidimensional insights to be recorded, analyzed, and acted upon, enabling scientific teams to drive innovation, accelerate evidence adoption, and shape healthcare outcomes through context-rich, intelligent workflows.
- Sector
- Healthcare
- HQ
- Marblehead, MA, United States
- Founded
- 2022
- Website
- posterosai.com/
- Ownership
- Privately Held (backing)
Posteros doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Posteros shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Posteros in its N-PORT filings yet. We sweep new filings monthly.